Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMIVANTAMAB vs AMLODIPINE\ATORVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMIVANTAMAB vs AMLODIPINE\ATORVASTATIN: Safety Overview

Metric AMIVANTAMAB AMLODIPINE\ATORVASTATIN
Total FAERS Reports 748 636
Deaths Reported 116 44
Death Rate 15.5% 6.9%
Hospitalizations 445 133
Average Patient Age 63.5 yrs 69.5 yrs
% Female Patients 65.3% 59.0%
Manufacturer Janssen Biotech, Inc. N/A
Route INTRAVENOUS N/A